아토피피부염에서 갈근황금황련탕 추출물의 ECS 조절을 통한 염증 완화 효과
Inflammation Relief Effect through ECS Control of Galgeunhwanggeumhwangryeon-tang Extract in Atopic Dermatitis
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective The purpose of this study was to confirm the effects of Galgeunhwanggeumhwangryeon-tang in reducing inflammation through the endocannabinoid system (ECS) control in atopic dermatitis. Methods 8-week-old Balb/C mice were divided into 4 groups: contorl group (Ctrl), lipid barrier elimination group (ADE), palmitoylethanolamide treated group after lipid barrier elimination (PEA), and Galgeunhwanggeumhwangryeon-tang applied group after lipid barrier elimination (GGRT). After inducing atopic dermatitis, cannabinoid receptor (CB) 1, CB2, CD68, phosphorylated inhibitor kappa B (p-IκB), inducible nitric oxide synthase (iNOS), substance P and serotonin were observed to confirm the regulation of the ECS, macrophage activity and mast cell activity. Results CB1 and CB2 showed higher positive reactions in the GGRT than in the LBE and PEA. CD68, p-IκB and iNOS showed higher positive reaction in the LBE, PEA and GGRT than in the Ctrl, but the increase in the positive reaction was lower in the GGRT compared to the LBE and PEA. Substance P and serotonin showed higher positive reaction in the LBE, PEA and GGRT than in the Ctrl, but the increase in the positive reaction was lower in the GGRT compared to the LBE and PEA. Conclusions The effects of Galgeunhwanggeumhwangryeon-tang were confirmed though the regulation of the ECS, macrophage activity and mast cell activity.
Abstract
Objective The purpose of this study was to confirm the effects of Galgeunhwanggeumhwangryeon-tang in reducing inflammation through the endocannabinoid system (ECS) control in atopic dermatitis. Methods 8-week-old Balb/C mice were divided into 4 groups: contorl group (Ctrl), lipid barrier elimination group (ADE), palmitoylethanolamide treated group after lipid barrier elimination (PEA), and Galgeunhwanggeumhwangryeon-tang applied group after lipid barrier elimination (GGRT). After inducing atopic dermatitis, cannabinoid receptor (CB) 1, CB2, CD68, phosphorylated inhibitor kappa B (p-IκB), inducible nitric oxide synthase (iNOS), substance P and serotonin were observed to confirm the regulation of the ECS, macrophage activity and mast cell activity. Results CB1 and CB2 showed higher positive reactions in the GGRT than in the LBE and PEA. CD68, p-IκB and iNOS showed higher positive reaction in the LBE, PEA and GGRT than in the Ctrl, but the increase in the positive reaction was lower in the GGRT compared to the LBE and PEA. Substance P and serotonin showed higher positive reaction in the LBE, PEA and GGRT than in the Ctrl, but the increase in the positive reaction was lower in the GGRT compared to the LBE and PEA. Conclusions The effects of Galgeunhwanggeumhwangryeon-tang were confirmed though the regulation of the ECS, macrophage activity and mast cell activity.
참고문헌 (32)
- 김정희, "아토피피부염의 최신지견", Allergy Asthma & Respiratory Disease, 14(1), pp.12~23 (2004), 대한 소아알레르기 호흡기학회
- Weidinger S, "Atopic dermatitis", Lancet(London, England), 387(10023), pp.1109~1122 (2016)
- Lee JY, "The clinical study of atopic dermatitis", J Pediatr Korean Med, 13(2), pp.171~186 (1999)
- 지혜미, "2006년 초등학생의 알레르기 질환 유병률의 전국적 역학조사", Allergy Asthma & Respiratory Disease, 19(2), pp.165~172 (2009), 대한 소아알레르기 호흡기학회
- 안강모, "2010년 한국 어린이·청소년의 천식, 알레르기 비결막염, 아토피피부염 증상 유병률 조사: 복합표본설계를 이용한 전국 서베이", 대한의사협회지, 54(7), pp.769~778 (2011), 대한의사협회
- Kim MJ, "A literature study of atopic dermatitis for children", J Pediatr Korean Med, 14(2), pp.167~182 (2000)
- Muluye RA, "Anti-inflammatory and antimicrobial effects of heat-clearing Chinese herbs:a current review", J Tradit Complement Med, 4(2), pp.93~98 (2014)
- 김홍배, "갈근추출액이 알레르기 염증반응에 미치는 영향", 대한한방소아과학회지, 23(3), pp.217~231 (2009), 대한한방소아과학회
- 안상현, "황금추출물의 지방장벽 생성을 통한 염증완화 효과", 대한한방소아과학회지, 35(1), pp.40~47 (2021), 대한한방소아과학회
- 양버들, "황금 추출물이 생쥐에 유발된 접촉피부염의 피부 증상에 미치는 영향", 동의생리병리학회지, 31(1), pp.59~64 (2017), 한의병리학회[DOI]
- 박영숙, "황금열수추출물이 DNCB로 유도된 알레르기성 접촉피부염 흰쥐의 항산화능 및 표피회복능에 미치는 영향", 한국식품영양과학회지, 35(6), pp.543~548 (2006), 한국식품영양과학회
- Chin LW, "Anti-herpes simplex virus effects of berberine from Coptidis Rhizoma, a major component of a Chinese herbal medicine, Ching-Wei-San", Arch Virol, 155(12), pp.1933~1941 (2010)
- 유영은, "한약재 추출물의 피부 염증 유발 세균에 대한 항균활성", 생명과학회지, 20(7), pp.1143~1150 (2010), 한국생명과학회
- 김희경, "황련이 화상조직에 미치는 항산화와 항염증 및 피부재생 효과", 대한한의학회지, 32(2), pp.1~13 (2011), 대한한의학회
- Baron ED, "Atopic dermatitis management: comparing the treatment patterns of dermatologists in Japan", U.S.A. and U.K. Br J Dermatol, 147, pp.710~715 (2002)
- Salzet M, "Invertebrate molecular neuroimmune processes", Brain Res Rev, 34(1), pp.69~79 (2000)
- Pacher P, "The endocannabinoid system as an emerging target of pharmacotherapy", Pharmacol Rev, 58(3), pp.389~462 (2006)
- Kupczyk P, "Cannabinoid system in the skin – a possible target for future therapies in dermatology", Exp Dermatol, 18(8), pp.669~679 (2009)
- Miller LK, "The highs and lows of cannabinoid receptor expression in disease : mechanisms and their therapeutic implications", Pharmacol Rev, 63(3), pp.461~470 (2011)
- Luger TA, "Neuromediators--a crucial component of the skin immune system", J Dermatol Sci, 30(2), pp.87~93 (2002)
- Maccarrone M, "The endocannabinoid system in human keratinocytes : evidence that anandamide inhibits epidermal differentiation through CB1receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase", J Biol Chem, 278(36), pp.33896~33903 (2003)
- Karsak M, "Attenuation of allergic contact dermatitis through the endocannabinoid system", Science, 316(5830), pp.1494~1497 (2007)
- Casanova ML, "Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors", J Clin Invest, 111(1), pp.43~50 (2003)
- Walker JM, "Cannabinoid mechanisms of pain suppression", Handb Exp Pharmacol, 168, pp.509~554 (2005)
- Jhaveri MD, "Endocannabinoid metabolism and uptake : novel targets for neuropathic and inflammatory pain", Br J Pharmacol, 152(5), pp.624~632 (2007)
- Tóth BI, "Endocannabinoids modulate human epidermal keratinocyte proliferation and survival via the sequential engagement of cannabinoid receptor-1 and transient receptor potential vanilloid-1", J Invest Dermatol, 131(5), pp.1095~1104 (2011)
- Tóth KF, "Cannabinoid signaling in the skin : therapeutic potential of the"C(ut)annabinoid"system", Molecules, 24(5), pp.918~ (2019)
- Arbabi S, "Mitogen-activated protein kinases", Crit Care Med, 30(1), pp.s74~s79 (2002)
- Chung, "Molecular inflammation : underpinnings of aging and age-related diseases", Ageing Res Rev, 8(1), pp.18~30 (2009)
- Baeuerle PA, "NF-kappa B : ten years after", Cell, 87(1), pp.13~20 (1996)
- Aktan F, "iNOS-mediated nitric oxide production and its regulation", Life Sciences, 75(6), pp.639~653 (2004)
- Kay AB, "Allergy and allergic diseases. First of two parts", N Engl J Med., 344(1), pp.30~37 (2001)